Novel Blood Biomarkers That Correlate With Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer’s Disease

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-180879
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2016English

MicroRNAs: Potential Biomarkers for Disease Diagnosis

Bio-Medical Materials and Engineering
MedicineBiomaterialsBiomedical Engineering
2014English

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis

Frontiers in Neurology
Neurology
2017English

Cognitive Reserve: Implications for Diagnosis and Prevention of Alzheimer’s Disease

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2004English

Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer’s Disease From Normal Aging

Journal of Geriatric Psychiatry and Neurology
PsychiatryGerontologyGeriatricsMental HealthNeurology
2019English

A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease

Neurology and Therapy
Neurology
2019English

Neuropathological Diagnosis of Vascular Cognitive Impairment and Vascular Dementia With Implications for Alzheimer’s Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2016English

Novel Biomarkers for Early Diagnosis and Progression of Diabetic Nephropathy

ARC Journal of Diabetes and Endocrinology
2015English

Steps to Standardization and Validation of Hippocampal Volumetry as a Biomarker in Clinical Trials and Diagnostic Criterion for Alzheimer’s Disease

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy